23.8 and 50.4 percent of those with one and two or more moderate risk factors were recommended aspirin prophylaxis
Similar Reduction Seen in Mortality for Exercise Patterns in Diabetes
Weekend warrior and regular activity patterns meeting current recommendations associated with reduced all-cause, CVD mortality
Myocardial Fibrosis Linked to Ventricular Arrhythmia in Male Endurance Athletes
Myocardial fibrosis remained predictive after adjusting for left ventricular end-diastolic volume indexed
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
Significantly lower risks seen for those receiving GLP-1 receptor agonists compared with other antidiabetic drugs
Prevalence of Extremely Severe Obesity Increasing in Children
2008 to 2023 saw relative increase of 253.1 percent for extremely severe obesity, which is linked to higher odds of metabolic complications
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
Increased cardiovascular risk over five years also seen in association with delayed diagnosis
Increased Risk for CVD Seen for Women With Premenstrual Disorders
Risk particularly pronounced for PMDs diagnosed before 25 years of age and those with comorbid perinatal depression
Nocturnal Hypertension Control Improved With Bedtime Antihypertensive Dosing
Better control of nocturnal blood pressure and improved circadian rhythm seen with bedtime versus daytime dosing